Solar urticaria


Cite item

Full Text

Abstract

Solar urticaria is defined as relatively rare photodermatosis induced by visible or ultraviolet (A) light. The diagnosis of the disease is based on the anamnesis and phototesting data. Management of the solar urticaria includes dark clothes, sunscreens, non-sedative antihistamines. Alternative interventions may be considered if high doses of non-sedative antihistamines are ineffective.

About the authors

E B Belan

Volgograd State Medical University

Email: belan.eleonora@yandex.ru
Russia

References

  1. Mageri M., Altrichter S., Borzova E. et al. The definition, diagnostic testing, and management of chronic inducible urticarias - The EAACI/GA2LEN/EDF/UNEC consensus recommendations 2016 update and revision. Allergy. 2016, v. 71, p. 780-802.
  2. Robert S.D. Prevalence of chronic photodermatoses in Scotland. Photodermatol. Photoimmunol. Photomed. 2009, v. 25, p. 59-60.
  3. Wei-Sheng Chong, Shih-Wee Khoo. Solar urticaria in Singapore: an uncommon photodermatosis seen in a tertiary dermatology center over a 10-year period. Photodermatology, Photoimmunology and Photomedicine. 2004, v. 20, p. 101-104.
  4. Horio T. Solar urticarial - idiopathic? Photodermatol. Photoimmunol. Photomed. 2003, v. 19, p. 147-154.
  5. Silpa-Archa N., Wongpraparut C., Leenutaphong V. Analysis of solar urticaria in Thai patients. Asian Pac. J. Allergy Immunol. 2016, v. 34, p. 146-152.
  6. Eguino P., Lasa O., Gardeazabal J. et al. Urticaria solar. Estudio de 20 casos. Actas Dermosifiliogr. 2005, v. 96, p. 25-29.
  7. Sussman G.L., Harvey R.P., Shocket A.L. Delayed pressure urticaria. Allergy Clin. Immunol. 1982, v. 70, p. 337-342.
  8. Du-Thanh A., Debu A., Lalheve P et al. Solar urticaria: a time-extended retrospective series of 61 patients and review of literature. European Journal of Dermatology. 2013, v. 23, p. 202-207.
  9. Botto N.C., Warshaw E.M. Solar urticaria. J. Am. Acad. Dermatol. 2008, v. 59, p. 909-920.
  10. Guttman-Yassky E., Hayek T., Muchnik L., Bergman R. Acute rhabdomyolysis and myoglobinuria associated with isotretinoin treatment. Int. J. Dermatol. 2003, v. 42, p. 499-500.
  11. Ferguson J., Dover J.S. Solar urticaria. Photodermatology. London: Manson Publishing. 2006.
  12. Ozaki H., Matsuyama T., Kawakubo Y., Ozawa A. A case of type IV solar urticaria identified by reverse in vitro serum test. Tokay. J. Exp. Clin. Med. 2003, v. 28, p. 51-55.
  13. Chong W.S., Shih-Wee Khoo. Solar urticaria in Singapore: an uncommon photodermatosis seen in a tertiary dermatology center over a 10-year period. Photodermatology, Photoimmunology and Photomedicine. 2004, v. 20, p. 101-104.
  14. Miyauchi H., Horio T. Detection of action, inhibition and augmentation spectra in solar urticarial. Dermatology. 1995, v. 191, p. 286-291.
  15. Kojima M., Horiko T, Nakamura Y., Aoki T. Solar urticaria: the relationship of photoallergen and action spectrum. Arch. Dermatol. 1986, v. 122, p. 550-555.
  16. Grabbe J. Pathomechanisms in Physical Urticaria. Journal of Investigative Dermatology Symposium Proceedings. 2001, v. 6, p. 135-136.
  17. Kuo S., Sivamani R.K. UVB-sensitive solar urticaria possibly associated with terbinafine. Dermatol. Online J. 2014, v. 20, p. 1087-2108.
  18. Sandy K., Raja K.S. UVB-sensitive solar urticaria possibly associated with terbinafine. Dermatology Online Journal. 2014, v. 20, p. 7.
  19. Fritsch C., Goerz G., Ruzicka T. Photodynamic therapy in dermatology. Arch. Dermatol. 1998, v. 134, p. 207-214.
  20. Kawada A., Hatanaka K., Gomi H., Matsuo I. In vitro phototoxicity of new quinolones: production of active oxygen species and photosensitized lipid peroxidation. Photodermatol. Photoimmunol. Photomed. 1999, v. 15, p. 226-230.
  21. Abajian M., Mlynek A., Maurer M. Physical urticaria. Curr. Allergy Asthma Rep. 2012, v. 12, p. 281-287.
  22. Roelandts R. Diagnosis and treatment of solar urticaria. Dermatol. Ther. 2003, v. 16 (1), p. 52-56.
  23. Botto N.C., Erin M.W. Solar urticarial. J. Am. Acad. Dermatol. 2008, v. 59, p. 909-920.
  24. Bolognia J.L., Jorizzo J.L., Rapini R.P. Dermatology. New York, Mosby. 2003, 1367 p.
  25. Magerl M., Borzova E., Gimenez-Arnau A. et al. The definitional diagnostic testing of physical and cholinergic urticarias. EAACI/GA2LEN/EDF/UNEV consensus panel recommendations. Allergy. 2009, v. 64, p. 1715-1721.
  26. European Dermatology Guideline for the photodermatoses 2. Phototesting Copenhagen http://www.turkderm.org.tr/turk-dermData/Uploads/files/murphy_guideline_phototesting.pdf.
  27. Faurschou A., Wulf H.C. Synergisctic effect of broad-spectrum sunscreens and antihistamines in the control of the idiopathic solar urticaria. Arch. Dermatol. 2008, v. 144, p. 765.
  28. Jauregui I., Ferrer M., Montoro J. et al. Antihistamines in the treatment of chronic urticarial. J. Investig. Allergol. Clin. Immunol. 2007, v. 17, p. 41-52.
  29. Beattie P.E., Dawe R.S., Ibbotson S.H., Ferguson J. Characteristics and prognosis of idiopathic solar urticarial: a cohort of 87 cases. Arch. Dermatol. 2003, v. 139, p. 1149-1154.
  30. Levi A., Enk C.D. Treatment of solar urticaria using antihistamine and leukotriene receptor antagonist combinations tailored to disease severity. Photodermatol. Photoimmunol. Photomed. 2015, v. 31, p. 302-306.
  31. Bilsland D., Ferguson J. A comparison of cetirizine and terfenadine in the management of solar urticaria. Photodermatol. Photoimmunol. Photomed. 1991, v. 8 (2), p. 62-64.
  32. Sanchez-Borges M., Caballero-Fonseca F., Capriles-Hulett A. Treatment of Recalcitrant Chronic Urticaria With Nonsedating Antihistamines: Is There Evidence for Updosing? J. Investig. Allergol. Clin. Immunol. 2013, v. 23, p. 141-144.
  33. Pont M., Delaporte E., Bonnevalle A., Thomas P. Solar urticaria: pre-PUVA UVA desensitization. Ann. Dermatol. Venereol. 2000, v. 127, p. 296-299.
  34. De Dios-Velazquez A., Gonzalez-de Arriba M., Beteta-Gorriti V. et al. Effectiveness of omalizumab in severe solar urticaria. Ann. Allergy Asthma Immunol. 2016, v. 116, p. 260-263.
  35. Aubin F., Avenel-Audran M., Jeanmougin M. et al. Omalizumab in patients with severe and refractory solar urticaria: a phase II multicentric study. J. Am. Acad. Dermatol. 2016, v. 74, p. 574-575.
  36. Duchini G., Bäumler W., Bircher A.J., Scherer K. Failure of omalizumab (Xolair®) in the treatment of a case of solar urticaria caused by ultraviolet A and visible light. Photodermatol. Photoimmunol. Photomed. 2011, v. 27, p. 336-337.
  37. Baliu-Piqué C., Aguilera Peiró P. J. Three cases of solar urticaria successfully treated with omalizumab. Eur. Acad. Dermatol. Venereol. 2016, v. 30 (4), p. 704-706.
  38. Arasi S., Crisafulli G., Caminiti L. et al. Treatment with omalizumab in a 16-year-old Caucasian girl with refractory solar urticaria. Pediatr. Allergy Immunol. 2015, v. 26 (6), p. 583-585.
  39. Metz M., Ohanyan T., Church M.K., Maurer M.J. Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis Dermatol. Sci. 2014, v. 73, p. 57-62.
  40. Levi A., Tal Y, Dranitzki Z. et al. Omalizumab in patient with severe and refractory solar urticaria: A phase II multicentric study. Pediatr. Allergy Immunol. 2015, v. 26 (6), p. 588-590.
  41. Güzelbey O., Ardelean E., Magerl M. et al. Successful treatment of solar urticaria with anti-immunoglobulin E therapy. Allergy. 2008, v. 3 (11), p. 1563-1565.
  42. Mang R., Stege H., Budde M.A. Successful treatment of solar urticaria by extracorporeal photochemotherapy (photopheresis). Photodermatol. Photoimmunol. Photomed. 2002, v. 18 (4), p. 196-198.
  43. Maksimovic L., Frémont G., Jeanmougin M. et al. Solar urticaria successfully treated with intravenous immunoglobulins. Dermatology. 2009, v. 218, p. 252-254.
  44. Lehmann P., Schwarz T. Photodermatoses: diagnosis and treatment. Dtsch. Arztebl. Int. 2011, v. 108 (9), p. 135-141.
  45. Kochevar I.E., Taylor C.R. Photophysics, photochemistry and photobiology. In: Fitzpatric: Dermatology in general medicine: Editors: Fredberg I.M., Eisa A.Z., Wolf K. et al. Mc Graw-Hill Inc, 6th ed. 2003, p. 1267-1275.

Copyright (c) 2016 Pharmarus Print Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies